Maciej S. Lesniak
Corresponding Author: Maciej S. Lesniak
MD, The Brain Tumor Center
The University of Chicago
Name/email consistency: high
- Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors. Wainwright, D.A., Sengupta, S., Han, Y., Lesniak, M.S. Neuro-oncology (2011)
- Advances in neuro-oncology: novel therapies and clinical trials. Lesniak, M.S. Expert. Rev. Anticancer. Ther (2007)
- Gene therapy for malignant glioma. Lesniak, M.S. Expert. Rev. Neurother (2006)
- Novel advances in drug delivery to brain cancer. Lesniak, M.S. Technol. Cancer Res. Treat. (2005)
- Brain tumors: controversies and challenges in management. Lesniak, M.S. Expert. Rev. Neurother (2005)
- Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Lesniak, M.S., Upadhyay, U., Goodwin, R., Tyler, B., Brem, H. Anticancer Res. (2005)
- Dexamethasone mediated inhibition of local IL-2 immunotherapy is dose dependent in experimental brain tumors. Lesniak, M.S., Gabikian, P., Tyler, B.M., Pardoll, D.M., Brem, H. J. Neurooncol. (2004)